Methods for treating nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) dysregulation in a host in need thereof using eggshell membrane compositions

Abstract

The present invention relates to the use of eggshell membrane compositions to activate levels of nuclear factor kappa-light-chain-enhancer of activated B cells (“NF-κB”) in the gut of a host in need thereof and methods of treating conditions related to NF-KB dysregulation. The herein invention provides a method for activating NF-κB in the gut of a host in need thereof. The method comprises orally administering an effective amount of a composition consisting essentially of eggshell membrane, and/or eggshell membrane isolates and/or eggshell membrane hydrolysates for activation of NF-κB to the host.

Dependencies are inferred from the claim text.